Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Naturally occurring pyrrolizidine alkaloids (PAs) are isolated from plants and other sources. The interest of the scientific community in these compounds owes itself to their high toxicity and biological activity, as well as to the challenge of synthesizing their pyrrolizidine scaffold. This review encompasses a wide range of topics found in the literature from 1995 to date, including the occurrence, biosynthesis, toxicity (hepatotoxicity, genotoxicity, and tumorigenicity), biological activity, and pharmacological properties (glycosidase inhibitory activity) of these secondary metabolites. Particular attention is given to the chemistry of PAs, addressing general strategies for formal and total syntheses via amino-based substrates, pyrroles, and pyrrolidine-based derivatives.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/bs.alkal.2018.03.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Serum ascites albumin gradient in predicting the severity of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids.
Clin Exp Hepatol
June 2025
School of Medicine, Southeast University, Nanjing, Jiangsu, China.
Aim Of The Study: Hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids (PA-HSOS) is a form of drug-induced liver injury (DILI) associated with portal hypertension (PH). The serum-ascites albumin gradient (SAAG) is known to be directly related to PH. However, the clinical value of SAAG for predicting the severity of PA-HSOS is unknown.
View Article and Find Full Text PDFNovel online-SPE configured UHPLC-MS/MS analysis to demystify the pyrrolizidine alkaloid contents of honey and bee pollen samples.
Food Chem
August 2025
Balparmak R&D Center, Altıparmak Food Industry and Trade Inc., Istanbul, Türkiye.
Pyrrolizidine alkaloids (PAs) and their N-oxides (PANOs) which might be incorporated into the bee products may pose health risks for consumers. We aimed to analyze PAs of honeys and bee pollens by quantifying 28 PAs/PANOs using a novel online SPE-UHPLC-MS/MS methodology. Dilute & shoot preparation was optimized for honeys, whereas pollen PAs were extracted using ACN/McIlvaine-EDTA buffer.
View Article and Find Full Text PDFGenus L.: Phytochemical Characterization and Bioactivity Evaluation for Drug Discovery.
Plants (Basel)
August 2025
RISE, Health Sciences Research Centre (CICS), University of Beira Interior, 6200-506 Covilhã, Portugal.
L. is a genus of flowering plants from the Boraginaceae family that includes several species traditionally used in herbal medicine. spp.
View Article and Find Full Text PDFThe underexplored pulmonary toxicity of pyrrolizidine alkaloids: Emerging hazard from food contamination.
Chem Biol Interact
August 2025
School of Medicine, The Chinese University of Hong Kong-Shenzhen, Shenzhen, 518172, China. Electronic address:
Pyrrolizidine alkaloids (PAs) are the most widespread plant-derived toxins globally. Humans are frequently exposed to PAs through ingestion of PA-contaminated food products, with chronic dietary exposure estimated at up to 48.4 ng/kg body weight/day, posing a significant global health threat.
View Article and Find Full Text PDFAlbumin-Bilirubin and Severity as Key Factors of Recovery in Patients With PA-HSOS Undergoing Transjugular Intrahepatic Portosystemic Shunt.
Ann Ital Chir
August 2025
Department of Infectious Diseases, Pujiang Branch of the First Affiliated Hospital, Zhejiang University School of Medicine, 321000 Jinhua, Zhejiang, China.
Aim: To evaluate the safety and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) in the management of pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome (PA-HSOS) and to identify key factors influencing the recovery of liver imaging manifestation after TIPS procedure in PA-HSOS patients.
Methods: A retrospective review was conducted of 30 PA-HSOS patients who received TIPS at Jinhua Municipal Central Hospital between 1 January 2018, and 30 September 2021, following failure of anticoagulation-based comprehensive treatments. Baseline characteristics and follow-up data were collected, including clinical manifestations, laboratory test results, computed tomography (CT) radiological manifestations of the liver, hepatic venous pressure gradient (HVPG), survival, and complications.